Pierre
Pierre Robin sequence (also known as Pierre Robin syndrome or Pierre Robin malformation) is a condition present at birth, in which the infant has a smaller than normal lower jaw (micrognathia), a tongue that falls back in the throat (glossoptosis), and difficulty breathing. The exact cause of Pierre Robin sequence is unknown. It is thought to occur as a result of a series of events during embryonic development.
Signs and Symptoms[edit]
The main symptoms of Pierre Robin sequence are a small lower jaw, a tongue that falls back in the throat, and difficulty breathing. Other symptoms may include cleft palate, feeding difficulties, choking episodes, failure to thrive, and speech difficulties.
Causes[edit]
The exact cause of Pierre Robin sequence is unknown. It is thought to occur as a result of a series of events during embryonic development. Some researchers believe that a problem with the development of the lower jaw bone (mandible) occurs first. As the mandible grows, the tongue is forced into the upper airway, which can lead to breathing problems and difficulty swallowing.
Diagnosis[edit]
Diagnosis of Pierre Robin sequence is usually made at birth or shortly thereafter, based on the presence of the characteristic signs and symptoms. In some cases, the condition may be detected during a prenatal ultrasound.
Treatment[edit]
Treatment for Pierre Robin sequence is aimed at managing the symptoms and supporting the child's breathing and feeding. This may include positioning the child on his or her stomach to help keep the airway open, using a feeding tube, and in some cases, surgery to correct the jaw or cleft palate.
Prognosis[edit]
The prognosis for children with Pierre Robin sequence varies. With appropriate treatment and management, most children can lead normal lives. However, some may have ongoing difficulties with speech and feeding.
See Also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian



